SALIX PHARMACEUTICALS LTD Business Combination, Contingent Consideration, Liability
SALIX PHARMACEUTICALS LTD had Business Combination, Contingent Consideration, Liability of $151.25 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2015-03-02
- 2014-12-31: Business Combination, Contingent Consideration, Liability $151.25M.
- 2014-09-30: Business Combination, Contingent Consideration, Liability $165.04M.
- 2014-06-30: Business Combination, Contingent Consideration, Liability $128.49M.
- 2014-03-31: Business Combination, Contingent Consideration, Liability $118.34M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2014-12-31 | $151.25M 10-K · filed 2015-03-02 |
| 2014-09-30 | $165.04M 10-Q/A · filed 2015-03-02 |
| 2014-06-30 | $128.49M 10-Q/A · filed 2015-03-02 |
| 2014-03-31 | $118.34M 10-Q/A · filed 2015-03-02 |
| 2013-12-31 | $87.30M 10-K · filed 2015-03-02 |
| 2013-12-27 | $87.30M 10-K · filed 2015-03-02 |
| 2013-09-30 | $110.50M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $108.10M 10-Q · filed 2013-08-09 |
| 2012-12-31 | $103.50M 10-K · filed 2015-03-02 |
| 2011-12-31 | $119.70M 10-K · filed 2015-03-02 |